Sven Ante Lundberg, Chief Scientific Officer at CRISPR Therapeutics AG (CRSP), bought 55,617 shares at $14.00 ($6K) on 2016-10-24, disclosed to the SEC on 2017-02-10.
Open-market purchase of $6k CRSP by Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 55,217 | $0 | 0.0% |
| 2 | $14.00 | 400 | $6K | 100.0% |
| Total | $0.10 avg | 55,617 | $6K | 100% |
| Filing → |
| MRUS | BUY | 2022-08-22 | $16K | — | Filing → |
| MRUS | BUY | 2022-07-13 | $199K | — | Filing → |